PMID- 34884536 OWN - NLM STAT- MEDLINE DCOM- 20211220 LR - 20211220 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 23 DP - 2021 Nov 25 TI - Investigation of H(2)S Donor Treatment on Neutrophil Extracellular Traps in Experimental Colitis. LID - 10.3390/ijms222312729 [doi] LID - 12729 AB - Inflammatory bowel diseases (IBD) are chronic, immune-mediated disorders, which affect the gastrointestinal tract with intermittent ulceration. It is increasingly clear that neutrophil extracellular traps (NETs) seem to have a role in IBD; however, the associated pathogenesis is still not known. Furthermore, several conventional therapies are available against IBD, although these might have side effects. Our current study aimed to investigate the effects of hydrogen sulfide (H(2)S) treatment on NETs formation and on the expression of inflammatory mediators in experimental rat colitis. To model IBD, 2,4,6-trinitrobenzenesulfonic acid (TNBS) was administered intracolonically (i.c.) to Wistar-Harlan male rats. Animals were treated (2 times/day) with H(2)S donor Lawesson's reagent per os. Our results showed that H(2)S treatment significantly decreased the extent of colonic lesions. Furthermore, the expression of members of NETs formation: peptidyl arginine deiminase 4 (PAD4), citrullinated histone H3 (citH3), myeloperoxidase (MPO) and inflammatory regulators, such as nuclear transcription factor-kappa B (NF-kappaB) and high-mobility group box 1 (HMGB1) were reduced in H(2)S treated group compared to TNBS. Additionally, H(2)S donor administration elevated the expression of ubiquitin C-terminal hydroxylase L1 (UCHL-1), a potential anti-inflammatory mediator. Taken together, our results showed that H(2)S may exert anti-inflammatory effect through the inhibition of NETs formation, which suggests a new therapeutic approach against IBD. FAU - Torok, Szilvia AU - Torok S AD - Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. FAU - Almasi, Nikoletta AU - Almasi N AD - Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. FAU - Valkusz, Zsuzsanna AU - Valkusz Z AD - Albert Szent-Gyorgyi Clinical Center, Department of Medicine, Medical Faculty, University of Szeged, H-6720 Szeged, Hungary. FAU - Posa, Aniko AU - Posa A AD - Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. AD - Interdisciplinary Excellence Center, Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. FAU - Varga, Csaba AU - Varga C AD - Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. FAU - Kupai, Krisztina AU - Kupai K AD - Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary. AD - Albert Szent-Gyorgyi Clinical Center, Department of Medicine, Medical Faculty, University of Szeged, H-6720 Szeged, Hungary. LA - eng PT - Journal Article DEP - 20211125 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Gasotransmitters) RN - 0 (Inflammation Mediators) RN - 0 (NF-kappa B) RN - 8T3HQG2ZC4 (Trinitrobenzenesulfonic Acid) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Colitis/chemically induced/*drug therapy/metabolism/pathology MH - Extracellular Traps/*drug effects MH - Gasotransmitters/pharmacology MH - Hydrogen Sulfide/*pharmacology MH - Inflammation Mediators/metabolism MH - Male MH - NF-kappa B/genetics/*metabolism MH - Rats MH - Rats, Wistar MH - Signal Transduction MH - Trinitrobenzenesulfonic Acid/*toxicity PMC - PMC8657984 OTO - NOTNLM OT - colitis OT - hydrogen sulfide OT - inflammation OT - inflammatory bowel disease OT - neutrophil extracellular traps COIS- The authors declare no conflict of interest. EDAT- 2021/12/11 06:00 MHDA- 2021/12/21 06:00 PMCR- 2021/11/25 CRDT- 2021/12/10 01:03 PHST- 2021/10/08 00:00 [received] PHST- 2021/11/18 00:00 [revised] PHST- 2021/11/22 00:00 [accepted] PHST- 2021/12/10 01:03 [entrez] PHST- 2021/12/11 06:00 [pubmed] PHST- 2021/12/21 06:00 [medline] PHST- 2021/11/25 00:00 [pmc-release] AID - ijms222312729 [pii] AID - ijms-22-12729 [pii] AID - 10.3390/ijms222312729 [doi] PST - epublish SO - Int J Mol Sci. 2021 Nov 25;22(23):12729. doi: 10.3390/ijms222312729.